The Effects of Nitric Oxide for Inhalation on Survival or the Need for Dialysis or a Right Ventricular Assistance Device (RVAD) in Right Ventricular Infarction Patients

Trial Profile

The Effects of Nitric Oxide for Inhalation on Survival or the Need for Dialysis or a Right Ventricular Assistance Device (RVAD) in Right Ventricular Infarction Patients

Discontinued
Phase of Trial: Phase II

Latest Information Update: 15 May 2016

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Myocardial infarction
  • Focus Therapeutic Use
  • Sponsors Ikaria Holdings; INO Therapeutics
  • Most Recent Events

    • 15 May 2016 Last checked against ClinicalTrials.gov record.
    • 23 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top